glycogen storage disease due to glucose-6-phosphatase deficiency type IA
glycogen storage disease due to glucose-6-phosphatase deficiency type IA
Explore linked clinical trials. Standard reference: MONDO:00092874 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, disorder of glycogen metabolism, glucose metabolism disease, glycogen storage disease I, glycogen storage disease due to glucose-6-phosphatase deficiency type IA, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, metabolic disease | Recruiting | Not stated | 2026-08-26 | NCT06636383 | |
| Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi renotubular syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, disorder of glycogen metabolism, glycogen storage disease I, glycogen storage disease Ib, glycogen storage disease due to GLUT2 deficiency, glycogen storage disease due to glucose-6-phosphatase deficiency type IA, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, kidney disorder, metabolic disease, renal tubular transport disease, urinary system disorder | Recruiting | Not stated | 2026-06-01 | NCT07459582 | |
| Accuracy of Lactate Meter in GSDIa | glycogen storage disease due to glucose-6-phosphatase deficiency type IA | Recruiting | Not stated | 2026-03-06 | NCT06843330 | |
| A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa) | glycogen storage disease due to glucose-6-phosphatase deficiency type IA | Recruiting | Phase 1 / Phase 2 | 2025-12-15 | NCT06735755 |